Edgestream Partners, L.P. Ptc Therapeutics, Inc. Transaction History
Edgestream Partners, L.P.
- $2.23 Billion
- Q3 2024
A detailed history of Edgestream Partners, L.P. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 30,383 shares of PTCT stock, worth $1.41 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
30,383
Previous 22,080
37.6%
Holding current value
$1.41 Million
Previous $675,000
66.96%
% of portfolio
0.05%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding PTCT
# of Institutions
224Shares Held
78MCall Options Held
144KPut Options Held
58.7K-
Vanguard Group Inc Valley Forge, PA9.13MShares$424 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$367 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$361 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$343 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$336 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.32B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...